Additionally, the presence of DCs and GC within these structures, alongside the representation of maturity through various markers CD21 and CD23, provided valuable insights into delineating the maturity stages of TLS associated with ccRCC tumors. The gene discussed is FCER2; the disease is nonpapillary renal cell carcinoma.